Search

Search Results
Results 13891 - 13900 of 89121 for cancer
  • James Bond affects the development of breasts!
    News - 1 Sep 2005
    Breakthrough Breast Cancer has announced that UK scientists have discovered that a gene - named after the James Bond villain Scaramanga - can trigger the development of breasts. This has important...
  • FDA approves Xeloda (capecitabine) oral chemotherapy
    News - 15 Jun 2005
    Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) -- an innovative oral chemotherapy -- for the adjuvant (post-surgery) treatment of patients...
  • Studies on Hormone Replacement Therapy (HRT) for breast cancer patients can give false hopes
    News - 20 May 2005
    Women treated for breast cancer who are considering taking Hormone Replacement Therapy (HRT) should be cautious when using published research to inform their decision. An article published today in...
  • Great news for breast cancer patients
    News - 12 May 2005
    In encouraging new study results researchers say that modern treatments have significantly boosted the 15-year survival rate for breast cancer, and even better news is that they have also found that...
  • Race influences how we cope with cancer
    News - 12 Apr 2005
    White patients cope better with the pressure of cancer than their British Asian counterparts according to research published on-line in the British Journal of Cancer.
  • Tamoxifen still not popular with women at risk of breast cancer
    News - 11 Apr 2005
    Tamoxifen still not popular with women at risk of breast cancer A new study has revealed that less than one in five women eligible to take tamoxifen decided to take the drug after being told of its...
  • Sobering facts on lung cancer
    News - 5 Apr 2005
    For up-to-date information about lung cancer, you can contact the Thomas G. Labrecque Foundation. The foundation was founded in 2002 by the Labrecque family in honor of Tom Labrecque, former chairman...
  • New prostate cancer test
    News - 28 Mar 2005
    Tessera, Inc., a Seattle-based biomedical company, has released its first product, ProstaMark EPCA (Early Prostate Cancer Antigen), as an Analyte Specific Reagent (ASR) for commercial use in pathology...
  • Lung cancer rates among men are on the decline
    News - 8 Mar 2005
    Results of the most comprehensive analysis to date of the impact of gender differences in lung cancer incidence in the United States indicate that lung cancer rates among men are on the decline, while...
  • Is it exercise or dieting that helps prevent cancer?
    News - 23 Feb 2005
    Scientists and health professionals have long believed that maintaining a healthy - or "ideal" - weight makes a difference in decreasing an individual's risk for cancer. But one lingering question is...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback